Meldungen zum Thema Medikament

D4L data4life gGmbH

Data4Life announces the appointment of Dr. Ben Illigens as new CEO by the Hasso Plattner Foundation

STADA Arzneimittel AG

Press release: Bio-Thera and STADA Extend Biosimilars Alliance to Tocilizumab

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES. Press release ...

Helmholtz Munich

2

New Endoscopy Technology Enables Early Detection of Esophageal Cancer

Technische Universität München

A new biotech hub for Munich

TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE A new biotech hub for Munich Where science powers start-ups: Launching BioLabs|TUM • TUM Venture Labs cooperate with BioLabs and Lilly • 1,800 square meters of coworking lab space • Aiming at accelerating therapy development BioLabs, TUM Venture Labs, and Eli Lilly and Company (Lilly) today launched BioLabs|TUM, a new biotechnology innovation hub in central Munich. The initiative aims to empower early-stage biotech start-ups ...

Helmholtz Munich

Therapeutic Vaccine for Chronic Hepatitis B Enters First Clinical Trial in Patients

CROMA-PHARMA GmbH

Croma-Pharma GmbH Announces Strategic Milestone as Novaestiq Corp. Joins Waldencast

Leobendorf, Austria (ots/PRNewswire) - Saypha® injectables to launch in the U.S. under the Obagi Medical brand, expanding global reach of Croma's science-driven aesthetic solutions Croma-Pharma GmbH, a global leader in minimally invasive aesthetic medicine, today announced the acquisition of Novaestiq Corp. by Waldencast plc (Nasdaq: WALD). Novaestiq, a joint venture ...

Syntellix AG

Singapore-Based Innovative Biomedical Start-Up Achieves “Strategic Triumph“ to Conquer Chinese Med-Tech Market

Hanover/Beijing/Singapore (ots) - ● NMPA grants Syntellix product approval for the world's most important future market with more than 1.4 billion people ● Syntellix‘ product approval for China is the largest and most important success in the company’s history; product approval in China was the company’s ...

Helmholtz Munich

Cancer Cachexia: Liver Identified as Driver of Body Wasting

Many people with cancer experience dramatic loss of muscle and fat tissue. In many cases, even the heart muscle is affected, which further weakens the body. This wasting syndrome, known as cachexia, affects around half of all cancer patients. It is a major cause of therapy resistance, complications, and increased mortality. ...

Helmholtz Munich

2

New Label-Free Imaging Tracks Cancer Treatment in Single Cells

Fraunhofer-Institut für Produktionstechnologie IPT

Transforming personalized medicine with AI-driven CAR-T manufacturing: Automated CAR-T cell production platform is ready for production

LTS Lohmann Therapie-Systeme AG

LTS and Nualtis Announce Strategic Cooperation to Expand Global Manufacturing Capabilities, Accelerate Market Expansion, and Ensure Customer Success

Andernach / Montreal (ots) - LTS LOHMANN Therapie-Systeme AG (LTS), a leading pharmaceutical technology company, and Nualtis (formerly IntelGenx Corp.), an innovator in oral thin film (OTF) drug delivery technology, today announced a strategic collaboration to provide customers with robust, reliable, high-quality ...

Hagleitner Hygiene International GmbH

Global Hygiene Expert Pittet: Hand Hygiene Saves 5 to 8 Million Lives Each Year

Mary Jane Berlin GmbH

Legalization turns Germany into a cannabis hotspot: Mary Jane becomes the world’s largest cannabis trade fair for the first time /500 international exhibitors and 60,000 visitors expected in Berlin – boom in medical cannabis

Berlin (ots) - About a year after partial legalization by the “traffic light” government coalition, Germany has become the key meeting point for the global cannabis scene. With 60,000 expected visitors, over 500 exhibitors, and an expanded festival area, Mary Jane Berlin will – for the first time since its ...

GEA Group Aktiengesellschaft

3

Key technology for bioprocesses

Grünenthal Group

Grünenthal announces acquisition of the rights to Cialis® from Lilly in Mexico, Brazil & Colombia

Aachen, Germany (ots) - - Grünenthal announces that it agreed to acquire the commercial rights to Cialis® from Eli Lilly and Company in Mexico, Brazil and Colombia, further strengthening Grünenthal's footprint in Latin America. - As part of the acquisition, Grünenthal will transfer the manufacturing of Cialis® to its production site in Chile. - Since 2017, ...

Asclea GmbH

x-cardiac and Hemedic Partner to Bring AI-Based Medical Devices to ICUs Across Scandinavia

Berlin/Copenhagen (ots) - x-cardiac GmbH, a leading provider of AI-based health solutions and a spin-off of the German Heart Center of Charité and Charité - Universitätsmedizin Berlin, announced today a strategic distribution partnership with the Danish company Hemedic ApS to expand the reach of its AI-based medical devices in Scandinavia. Through this partnership, ...

Grünenthal Group

Maren Thurow starts as new Head Global Communications at Grünenthal

Technische Universität München

Identifying pathogens within minutes instead of days

TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE Mass spectrometry detects bacteria without time-consuming isolation and multiplication Identifying pathogens within minutes instead of days - Identification directly in tissue and stool samples - So far 232 medically important bacterial species detectable - Database must now be further expanded Speed and reliability are crucial in the diagnosis of diseases. Researchers at the ...

Acousia Therapeutics GmbH

Acousia Therapeutics Reaches 50% Patient Enrollment Milestone in Phase 2 PROHEAR Study

Tübingen, Germany (ots) - Acousia Therapeutics GmbH announced that it has successfully enrolled 50% of patients in its ongoing Phase 2 clinical trial, the PROHEAR Study, evaluating ACOU085 (INN: bimokalner) for the prevention of cisplatin-induced hearing loss in patients with testicular cancer undergoing chemotherapy. Cisplatin is a cornerstone in modern oncology and ...

Gerresheimer AG

Centor Launches Smart Pill Organizer to Support Medication Adherence

Helmholtz Munich

Helmholtz Launches Task Force to Strengthen Prevention Research

PNO Innovation GmbH

canSERV Open Call relaunches: Apply now for Free Access to Cutting-Edge Cancer Research Services

DHL Group

4

PM: DHL liefert die erste mobile Herzklinik nach Burundi / PR: DHL delivers the world's first mobile heart clinic to Burundi

PNO Innovation GmbH

SGLT2 HYPE: New EU-funded Project Aims to Transform Hypertension Treatment